Valuation: MiniMed Group, Inc.

Market Cap 5.48B 4.74B 4.43B 4.05B 7.63B 522B 7.75B 51.96B 20.39B 261B 20.56B 20.11B 870B P/E 2027 *
31.2x
P/E 2028 * 30.7x
Enterprise Value 5.08B 4.4B 4.11B 3.76B 7.08B 485B 7.2B 48.24B 18.93B 243B 19.09B 18.67B 808B EV / Sales 2027 *
1.49x
EV / Sales 2028 * 1.32x
Free-Float
9.28%
Yield 2027 *
-
Yield 2028 * -
1 day-0.51%
1 week+2.09%
Current month+8.03%
1 month+27.53%
3 months+68.54%
1 week 18.19
Extreme 18.1866
19.92
1 month 14.78
Extreme 14.7811
19.92
Current year 10.65
Extreme 10.65
20.48
1 year 10.65
Extreme 10.65
20.48
3 years 10.65
Extreme 10.65
20.48
5 years 10.65
Extreme 10.65
20.48
10 years 10.65
Extreme 10.65
20.48
Date Insider Type Main position Quantity % Market Cap.
7/31/26 Tax

Chief Executive Officer

-31,350 0.0112%
7/31/26 Tax

Chief Technology Officer

-8,012 0.0029%
7/31/26 Tax

General Counsel

-1,762 0.0006%
Change 5-day change 1-year change 3-year change Capi.($)
-0.51%+2.09% - - 5.48B
+0.41%+0.92%+35.55%+31.24% 12.84B
-0.21%-0.42%+20.21%+26.79% 6.87B
+5.64%+9.50%+59.16%+38.76% 6.51B
+1.20%-4.46%-26.80%+39.65% 4.41B
+0.77%-2.17%-21.87%-17.42% 4.08B
+5.61%+12.99%+55.53%-43.62% 2.02B
-4.66%-7.06%-21.00%+133.83% 1.73B
+0.92%+6.50%+68.55%-10.15% 1.71B
+1.13%+3.03%-28.31%-43.47% 1.32B
Average +1.03%+753.18%+15.67%+17.29% 4.7B
Weighted average by Cap. +1.12%+756.49%+22.38%+24.36%

Financials

2027 *2028 *
Net sales 3.42B 2.96B 2.77B 2.53B 4.77B 326B 4.84B 32.47B 12.74B 163B 12.85B 12.57B 544B 3.7B 3.2B 2.99B 2.74B 5.16B 353B 5.24B 35.12B 13.78B 177B 13.9B 13.59B 588B
Net income 175M 152M 142M 129M 244M 16.7B 248M 1.66B 652M 8.35B 657M 643M 27.82B 207M 179M 168M 153M 289M 19.77B 293M 1.97B 772M 9.89B 778M 761M 32.94B
Net Debt -393M -340M -318M -290M -547M -37.45B -556M -3.73B -1.46B -18.73B -1.47B -1.44B -62.4B -601M -520M -486M -444M -837M -57.29B -850M -5.7B -2.24B -28.66B -2.26B -2.21B -95.46B
Logo MiniMed Group, Inc.
MiniMed Group, Inc. is a medical technology company, which develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Its fully integrated system addresses pain points for people with diabetes (PWD): health outcomes and complexity of diabetes management. The MiniMed 780G is its flagship AID system. The MiniMed 780G system uses its SmartGuard dosing algorithm technology, which automatically delivers basal insulin and auto-correction doses every five minutes based on sensor glucose readings. The MiniMed 780G consists of the MiniMed 780G insulin pump, the Simplera Sync CGM sensor, and the instinct sensor. Its platform of clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and a Smart Multiple Daily Injection (MDI) System. Its pipeline products are the MiniMed Flex, screenless insulin pump, next-generation Vivera dosing algorithm, and MiniMed Fit patch pump with extended wear.
Employees
-
Date Price Change Volume
26-08-10 US$19.50 -0.51% 1,076,488
26-08-07 US$19.60 +6.41% 1,629,894
26-08-06 US$18.42 -0.75% 499,796
26-08-05 US$18.56 -2.26% 1,043,498
26-08-04 US$18.99 -0.58% 1,045,013
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
19.50USD
Average target price
21.36USD
Spread / Average Target
+9.56%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MMED Stock